Robert Muni Lofra
Dr Anna Mayhew
Professor Chiara Marini Bettolo
| Assessing disease progression in spinal muscular atrophy, current gaps, and opportunities: a narrative review | 2025 |
|
Dr Anna Mayhew
Catherine Turner
Jassi Sodhi
Meredith James
Adam Kerr
et al. | Delivery of physiotherapy and occupational therapy standards of care for Duchenne muscular dystrophy: Key recommendations based on UK web-based survey | 2025 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study | 2024 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3 | 2024 |
|
Dr Marianela Schiava
Robert Muni Lofra
Dr John Bourke
Meredith James
Professor Jordi Diaz Manera
et al. | Disease-associated comorbidities, medication records and anthropometric measures in adults with Duchenne muscular dystrophy | 2024 |
|
Dr Marianela Schiava
Dr Anna Mayhew
Professor Michela Guglieri
| Factors Associated With Early Motor Function Trajectories in DMD After Glucocorticoid Initiation: Post Hoc Analysis of the FOR-DMD Trial | 2024 |
|
Dr Marianela Schiava
Dr John Bourke
Meredith James
Dr Maha Elseed
Dr Monika Malinova
et al. | Functional abilities, respiratory and cardiac function in a large cohort of adults with Duchenne muscular dystrophy treated with glucocorticoids | 2024 |
|
Dr Ursula Moore
Dr Anna Mayhew
Heather Hilsden
Dr Hai The Pham
Meredith James
et al. | Performance of upper limb entry item to predict forced vital capacity in dysferlin-deficient limb girdle muscular dystrophy | 2024 |
|
Dr Marianela Schiava
Dr Anna Mayhew
Professor Michela Guglieri
| Reference curves of motor function outcomes in young steroid-naïve males with Duchenne muscular dystrophy | 2024 |
|
Meredith James
Professor Michela Guglieri
Dr Anna Mayhew
| Understanding North Star Ambulatory Assessment total scores and their implications for standards of care using observational data | 2024 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| 2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants | 2023 |
|
Dr Claire Wood
Dr Kieren Hollingsworth
Edrina Bokaie
Dr Eric Hughes
Robert Muni Lofra
et al. | Is ongoing testosterone required after pubertal induction in Duchenne muscular dystrophy? | 2023 |
|
Dr Ursula Moore
Esther Fernández-Simón
Dr Marianela Schiava
Daniel Cox
Meredith James
et al. | Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy | 2023 |
|
Dr Anna Mayhew
Dionne Moat
Robert Muni Lofra
Jassi Sodhi
| Adult North Star Network (ANSN): Consensus Document for Therapists Working with Adults with Duchenne Muscular Dystrophy (DMD) - Therapy Guidelines | 2022 |
|
Meredith James
Dr Michelle Eagle
Robert Muni Lofra
Dr ursula Moore
Professor Michela Guglieri
et al. | Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale | 2022 |
|
Dr Anna Mayhew
Meredith James
Dr ursula Moore
Helen Sutherland
Robert Muni Lofra
et al. | Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach | 2022 |
|
Dr ursula Moore
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Dr Lizzie Harris
et al. | Cardiac and pulmonary findings in dysferlinopathy: A 3-year, longitudinal study | 2022 |
|
Dr Marianela Schiava
Dr Henriette van Ruiten
Dr Anna Mayhew
Emerita Professor Elaine McColl
Dr Tracey Willis
et al. | Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy. | 2022 |
|
Meredith James
Dr Anna Mayhew
Emerita Professor Katherine Bushby
Professor Volker Straub
| Comparison of strength testing modalities in dysferlinopathy | 2022 |
|
Dr Anna Mayhew
Professor Michela Guglieri
| Editorial: Lessons Learned from Translational Research in Neuromuscular Diseases: Impact on Study Design, Outcome Measures and Managing Expectation | 2022 |
|
Dr Anna Mayhew
Dionne Moat
Dr Michelle Eagle
Meredith James
Robert Muni Lofra
et al. | Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy | 2022 |
|
Professor Michela Guglieri
Dr Anna Mayhew
| Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial | 2022 |
|
Robert Muni Lofra
Dr Lindsay Murphy
Professor Chiara Marini Bettolo
Dr Anna Mayhew
| Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK | 2022 |
|
Dr Anna Mayhew
Professor Volker Straub
Professor Chiara Marini Bettolo
| Revised Hammersmith Scale for spinal muscular atrophy: Inter and intra-rater reliability and agreement | 2022 |
|
Dr Fiona Smith
Dr Ian Wilson
Roberto Fernandez-Torron
Meredith James
Dr Ursula Moore
et al. | Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy | 2022 |
|
Meredith James
Robert Muni Lofra
Dionne Moat
Mark Richardson
Dr Michelle Eagle
et al. | Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies | 2022 |
|
Dr ursula Moore
Dr Fiona Smith
Dr Ian Wilson
Meredith James
Dr Anna Mayhew
et al. | Water T2 could predict functional decline in patients with dysferlinopathy | 2022 |
|
Robert Muni Lofra
Ruth Wake
Dr Anna Mayhew
Professor Chiara Marini Bettolo
| Longitudinal changes in respiratory and upper limb function in a pediatric type III spinal muscular atrophy cohort after loss of ambulation | 2021 |
|
Dr Ursula Moore
Meredith James
Dr Anna Mayhew
Professor Michela Guglieri
Roberto Fernandez-Torron
et al. | Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease | 2021 |
|
Mark Richardson
Dr Anna Mayhew
Robert Muni Lofra
Dr Lindsay Murphy
Professor Volker Straub
et al. | Prevalence of pain within limb girdle muscular dystrophy r9 and implications for other degenerative diseases | 2021 |
|
Dr Claire Wood
Dr Kieren Hollingsworth
Dr Eric Hughes
Dr Sadha Punniyakodi
Robert Muni Lofra
et al. | Pubertal induction in adolescents with DMD is associated with high satisfaction, gonadotropin release and increased muscle contractile surface area | 2021 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Chiara Marini Bettolo
| Clinical Variability in Spinal Muscular Atrophy Type III | 2020 |
|
Dr Ursula Moore
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Professor Andrew Blamire
et al. | Intensive Teenage Activity Is Associated With Greater Muscle Hyperintensity on T1W Magnetic Resonance Imaging in Adults With Dysferlinopathy | 2020 |
|
Dr Anna Mayhew
Roberto Fernandez-Torron
Dr Michelle Eagle
Karen Bettinson
Professor Andrew Blamire
et al. | Assessment of disease progression in dysferlinopathy – a 1 year cohort study | 2019 |
|
Dr Anna Mayhew
Professor Michela Guglieri
| Categorising trajectories and individual item changes of the North Star Ambulatory Assessment in patients with Duchenne muscular dystrophy | 2019 |
|
Dr Alex Murphy
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
Dr Kieren Hollingsworth
et al. | Natural history of limb girdle musclar dystrophy R9 over 6 years: searching for trial endpoints | 2019 |
|
Dr Claire Wood
Professor Timothy Cheetham
Dr Kieren Hollingsworth
Professor Michela Guglieri
Dr Anna Mayhew
et al. | Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy | 2019 |
|
Dr Anna Mayhew
Meredith James
Professor Volker Straub
| Performance of Upper Limb module for Duchenne muscular dystrophy | 2019 |
|
Dr Anna Mayhew
Robert Muni Lofra
Professor Volker Straub
| Revised upper limb module for spinal muscular atrophy: 12 month changes | 2019 |
|
Professor Jordi Diaz Manera
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Dr Fiona Smith
et al. | Muscle MRI in dysferlinopathy patients: Pattern recognition and implications for clinical trials | 2018 |
|
Dr Anna Mayhew
Robert Muni Lofra
| Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function | 2018 |
|
Dr Ursula Moore
Roberto Fernandez-Torron
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
et al. | Teenage exercise is associated with earlier symptom onset in dysferlinopathy: a retrospective cohort study | 2018 |
|
Dr Anna Mayhew
| Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM | 2017 |
|
Libby Wood
Professor Chiara Marini Bettolo
Professor Michela Guglieri
Dr Grace McMacken
Dr Anna Mayhew
et al. | Respiratory involvement in ambulant and non-ambulant patients with facioscapulohumeral muscular dystrophy | 2017 |
|
Dr Ursula Moore
Meredith James
Dr Anna Mayhew
Dr Fiona Smith
Dr Lizzie Harris
et al. | Clinical outcome study for dysferlinopathy: One-year follow-up | 2016 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Professor Michela Guglieri
Professor Volker Straub
Professor Hanns Lochmuller
et al. | Corrigendum to Development and psychometric analysis of the Duchenne muscular dystrophy Functional Ability Self-Assessment Tool (DMDSAT) (vol 25, pg 937, 2015) | 2016 |
|
Dr Michelle Eagle
Dr Anna Mayhew
Professor Michela Guglieri
Professor Volker Straub
| Outcome measures for Duchenne muscular dystrophy from ambulant to non-ambulant: Implications for clinical trials | 2016 |
|
David Rawlings
Dr Claire Wood
Professor Timothy Cheetham
Dr Cecilia Jimenez Moreno
Dr Anna Mayhew
et al. | Prophylactic oral bisphosphonate therapy in duchenne muscular dystrophy | 2016 |
|
Dr Anna Mayhew
Emerita Professor Katherine Bushby
| Revised Hammersmith scale for spinal muscular atrophy: Longitudinal changes over six and twelve months in a large international cohort | 2016 |
|
Dr Lizzie Harris
Dr Catherine Bladen
Dr Anna Mayhew
Meredith James
Karen Bettinson
et al. | The Clinical Outcome Study for dysferlinopathy: An international multicenter study | 2016 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Professor Michela Guglieri
Professor Volker Straub
Professor Hanns Lochmuller
et al. | Development and Psychometric Analysis of the Duchenne Muscular Dystrophy Functional Ability Self-Assessment Tool (DMDSAT) | 2015 |
|
Dr Cecilia Jimenez Moreno
Dr Sira Moreno
Dr Michelle Eagle
Dr Anna Mayhew
Meredith James
et al. | Impact of three decades of improvement in standards of care for Duchenne muscular dystrophy | 2015 |
|
Dr Stephen Lynn
Professor Annemieke Aartsma-Rus
Emerita Professor Katherine Bushby
Dr Anna Mayhew
Professor Volker Straub
et al. | Measuring clinical effectiveness of medicinal products for the treatment of Duchenne muscular dystrophy | 2015 |
|
Dr Anna Mayhew
Meredith James
Dr Michelle Eagle
Dr Catherine Bladen
Karen Bettinson
et al. | Preparation of a disease specific functional measure suitable for trials in dysferlinopathy | 2015 |
|
Dr Lizzie Harris
Karen Bettinson
Meredith James
Dr Anna Mayhew
Dr Michelle Eagle
et al. | International Clinical Outcome Study in Dysferlinopathy (COS): Results of screening questionnaires in UK patients | 2014 |
|
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al. | Quantitative Magnetic Resonance Imaging in Limb-Girdle Muscular Dystrophy 2I: A Multinational Cross-Sectional Study | 2014 |
|
Dr Michelle Eagle
Dr Anna Mayhew
Karen Bettinson
Meredith James
Dr Brigitta von Rekowski
et al. | Clinical outcome measures for dysferlinopathy: An exploration of reliability and suitability of novel functional rating scales | 2013 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
| Detecting meaningful change using the North Star Ambulatory Assessment in Duchenne muscular dystrophy | 2013 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Meredith James
Emerita Professor Katherine Bushby
| Performance of Upper Limb Scale for use in Duchenne muscular dystrophy - An iterative process to establish its suitability for clinical trials | 2013 |
|
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al. | Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study | 2013 |
|
Meredith James
Dr Michelle Eagle
Dr Anna Mayhew
| Clinical Evaluator training for the GSK DEMAND programme | 2012 |
|
Dr Michelle Eagle
Dr Anna Mayhew
Dr Eugen-Matthias Strehle
| Development of a Functional Assessment Scale for Ambulatory Boys with Duchenne Muscular Dystrophy | 2012 |
|
Dr Michelle Eagle
Dr Anna Mayhew
| Development of an upper limb functional scale in dystrophinopathies | 2012 |
|
Dr Anna Mayhew
Dr Michelle Eagle
| Exploratory Rasch analysis of the EK2 scale used in a population of Duchenne muscular dystrophy (DMD) | 2012 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
| Trial readiness: Clinical interpretability of change scores of the North Star Ambulatory Assessment in Duchenne muscular dystropy | 2012 |
|
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al. | Assessing muscle pathology by MRI in LGMD2I | 2011 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Dr Tracey Willis
Professor Volker Straub
| Exploratory Rasch analysis of adapted North Star ambulatory assessment in LGMD 2I | 2011 |
|
Dr Anna Mayhew
Dr Michelle Eagle
Emerita Professor Katherine Bushby
Professor Volker Straub
Dr Anna Sarkozy
et al. | Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy | 2011 |
|
Dr Tracey Willis
Dr Kieren Hollingsworth
Dr Michelle Eagle
Dr Anna Mayhew
Emerita Professor Katherine Bushby
et al. | Quantitative MRI in LGMD2I; a longitudinal study | 2011 |
|
Dr Michelle Eagle
Dr Anna Mayhew
Dr Tracey Willis
Professor Hanns Lochmuller
Emerita Professor Katherine Bushby
et al. | Functional outcome measures in limb girdle muscular dystrophy 21: Correlations with MRI | 2010 |
|
